Chengdu Maxvax Biotechnology
PrivateLast Round
Series D
Extension
Dec 25, 2025
Total Funding Raised
$359.84M
Company Overview
Chengdu Maxvax Biotechnology is a biopharmaceutical company that specializes in the research, development, manufacturing, and commercialization of innovative vaccines and novel adjuvants.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chengdu Maxvax Biotechnology Comparables
Compare Chengdu Maxvax Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WestVac Biopharma Co., Ltd. | 81% | |
| Abogen Biosciences | 81% | |
| RecBio | 78% | |
Chengdu Maxvax Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Dec 25, 2025 | ||||
| Series D | Oct 31, 2025 | ||||
| Series C Extension | Jun 11, 2024 | ||||
| Series C | Feb 6, 2024 | ||||
| Series B Extension | Dec 7, 2022 | ||||
Series B | Jul 20, 2022 |
Chengdu Maxvax Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GF Qianhe Investment | Series B Extension |
| IDG Capital | Series D, Series C Extension |
| Korea Investment Partners | Pre Seed |
| Hillhouse Investment | Series B, Series A |
| Gortune Investment | Series B Extension |
| Korea Investment Partners | Series A |
| Guohai Innovation Capital Investment Management | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 11, 2024
$41.4M round led by IDG Capital
- Dec 7, 2022
$43M round led by GF Qianhe Investment.
Chengdu Maxvax Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Chengdu Maxvax Biotechnology's valuation, stock price, and market status.